Send to

Choose Destination
J Endocrinol Invest. 2006 Dec;29(11):RC31-4.

Intracerebroventricular acute and chronic administration of obestatin minimally affect food intake but not weight gain in the rat.

Author information

Department of Pharmacology, Chemoterapy, and Medical Toxicology, University of Milan, Via Vanvitelli 32, 20129 Milan, Italy.


We studied the effect of the acute central administration of obestatin on food intake and body weight in short-term starved male rats, and those of 28-day continuous intracerebroventricular (icv) infusion of obestatin in free feeding rats. In 16-h starved rats, obestatin induced a trend toward a reduction of food intake that did not reach statistical significance. In fed rats, the icv infusion of obestatin significantly decreased food consumption in the first day of treatment; but the anorexigenic effect of obestatin vanished thereafter. Interestingly, the body weight of rats infused for 28 days with obestatin was superimposable to that of the respective control at all time intervals. In all, our results indicate that the anorexigenic effect of obestatin is of little account and that the peptide does not modify energy metabolism in the long-term administration.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center